Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
Key facts
- Where
- Al Mansurah, EgyiptomSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 70 years old?
Source: NCT06518473, who can take part
Where in Egyiptom
- Mohamed AbdElmoniemAl Mansurah, EgyiptomNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Mansoura University Hospital
- Trial code
- NCT06518473
- Record updated
- 2026. augusztus 18.
- Original description
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.Read full original descriptionShow less
The Relation Between Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.
The presence of non-fully reversible airflow obstruction (FEV1/FVC < 0.7 post-bronchodilation) measured by spirometry confirms the diagnosis of COPD
Inclusion: Adults aged 40-70 years diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 criteria.
Exclusion: Recent respiratory infections or use of systemic corticosteroids within the last month before enrollment; Patients with known allergic diseases before enrollment; Patients with associated other chronic respiratory disorders; Patients with significant comorbidities that could influence respiratory function.